Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  CareDx, Inc    CDNA

CAREDX, INC

(CDNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/20/2021 01/21/2021 01/22/2021 01/25/2021 01/26/2021 Date
95.6(c) 87.66(c) 85.43(c) 85.7(c) 78.96(c) Last
1 030 157 1 993 547 1 002 212 844 845 845 041 Volume
+2.43% -8.31% -2.54% +0.32% -7.86% Change
More quotes
Financials (USD)
Sales 2020 192 M - -
Net income 2020 -22,0 M - -
Net Debt 2020 - - -
P/E ratio 2020 -166x
Yield 2020 -
Sales 2021 250 M - -
Net income 2021 -14,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -263x
Yield 2021 -
Capitalization 4 041 M 4 041 M -
Capi. / Sales 2020 21,0x
Capi. / Sales 2021 16,2x
Nbr of Employees 346
Free-Float 98,4%
More Financials
Company
CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with... 
More about the company
Notations Surperformance© of CareDx, Inc
Trading Rating : Investor Rating :
More Ratings
All news about CAREDX, INC
01/25CareDx Announces Closing of Public Offering of Common Stock
GL
01/21INSIDER TRENDS : CareDx Insider Sale for Taxes Adds to 90-Day Selling Trend
MT
01/21CAREDX, INC. : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
01/21CAREDX : Prices $175 Million Public Offering
MT
01/20CareDx Announces Pricing of Public Offering of Common Stock
GL
01/20CAREDX : Insider at CareDx (CDNA) Makes Significant Sale of Stock
MT
01/19CareDx to Pubicly Offer up to $201.3 Million in Common Shares, Including Over..
MT
01/19CareDx Announces Proposed Public Offering of Common Stock
GL
01/19INSIDER TRENDS : CareDx Insider Extends 90-Day Selling Trend
MT
01/11CAREDX : Expects Preliminary Q4 Revenue Above Street Forecasts
MT
01/11CAREDX, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/11CAREDX : Reports Preliminary Fourth Quarter and Full Year 2020 Results
AQ
01/08CAREDX : to Acquire TransChart For Undisclosed Amount
MT
01/08CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 C..
GL
01/08CareDx Transplant Leadership Showcased at ASTS 2021
GL
More news
News in other languages on CAREDX, INC
2019CAREDX INC : Veröffentlichung des Jahresergebnisses
2019CAREDX INC : publication des résultats annuels
2016CAREDX : Un centre européen de suivi de la greffe cardiaque à Strasbourg
2016CAREDX INC : publication des résultats annuels
More news
Analyst Recommendations on CAREDX, INC
More recommendations
Chart CAREDX, INC
Duration : Period :
CareDx, Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CAREDX, INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 82,83 $
Last Close Price 78,96 $
Spread / Highest target 27,9%
Spread / Average Target 4,91%
Spread / Lowest Target -30,3%
EPS Revisions
Managers and Directors
NameTitle
Reginald Seeto President, Chief Executive Officer & Director
Peter K. Maag Chairman
Paul Ciccolella Senior Vice President-Global Operations
Marcel Konrad Controller, Chief Financial & Accounting Officer
Robert N. Woodward Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
CAREDX, INC8.99%4 041
EXACT SCIENCES CORPORATION6.45%22 430
GUARDANT HEALTH, INC.16.32%14 987
BGI GENOMICS CO., LTD.31.71%9 670
INVITAE CORPORATION15.16%9 123
ADAPTIVE BIOTECHNOLOGIES CORPORATION5.09%8 499